NCT02152228View on ClinicalTrials.gov

A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

July 31, 2015

Conditions

Hypoparathyroidism

Interventions

DRUG

EnteraBio's Oral Parathyroid Hormone (1-34)

Oral administration

Trial Locations (1)

35152

Lin Medical Center, Haifa

Sponsors

Lead Sponsor

Entera Bio Ltd.

All Listed Sponsors

lead

Entera Bio Ltd.

INDUSTRY